New hope for rare immune disorder: first human trial begins
Disease control
Recruiting now
This early-stage study tests a new drug called IMSB301 in people with a rare group of diseases called type 1 interferonopathies, where the immune system is overactive. The main goal is to check if the drug is safe and how it moves through the body. Only 6 participants are being e…
Phase: PHASE1 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control
Last updated May 02, 2026 18:45 UTC